Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source

Source document· March 5, 2026

Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering

View original at finance.yahoo.com

Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering Dataset grows to more than 312,000 whole genomes with longitudinal clinical data GSK is one of the first to lead a further expansion of 50,000 whole genomes paired with proteomic data SAN DIEGO, March 5, 20…

Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

There is proven value in the integration of proteomics and comprehensive datasets, evidenced by the boon of large-scale studies showing promise in pinpointing drug targets linked to human disease
80% confidence
AGD has already enabled disease-impacting discoveries in autoimmune disease and obesity, with many more such studies underway, and continued expansion accelerates this progress
80% confidence
Human genetics is the most powerful compass we have for finding the right targets and delivering the best innovative medicines
80% confidence
Integrating high-quality clinical and genomic data with advanced AI will help pharma translate discoveries into meaningful advances for patients
80% confidence
The AGD dataset is among the largest collections of whole genome sequences available, and it is the world's largest pairing of whole genome sequences with the depth of clinical data that comes from a leading academic medical center
80% confidence
Vanderbilt has an exceptional biobank and population-scale genetics program — one of the most impressive in the world
80% confidence